Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVERT Shock: Vasopressin in traumatic shock
NCT01611935Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- May 2013
- Primary completion
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of vasopressin in Traumatic shock, sponsored by University of Pennsylvania. Started May 2013; status: completed.
02
Drugs
vasopressin
03
Conditions
Traumatic shock
Beyond the preview
Go deeper on NCT01611935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611935.